Trastuzumab Deruxtecan in Low or Ultralow HER2 Metastatic Breast Cancer

N Engl J Med. 2025 Feb 20;392(8):830. doi: 10.1056/NEJMc2416654.

Authors

Fabio Conforti¹, Chiara Oriecuia², Laura Pala³

Affiliations

¹ University of Milan, Milan.
² University of Brescia, Brescia, Italy.
³ Humanitas Gavazzeni, Bergamo, Italy.

PMID: 39970413
DOI: 10.1056/NEJMc2416654

No abstract available

Publication types

Letter
Comment